未登录 分享 收藏
分享 收藏
分享 收藏
A plain language summary of the preliminary results for encorafenib plus binimetinib and pembrolizumab in adults with BRAF V600-mutant melanoma in the STARBOARD study STARBOARD研究中，encorafenib联合binimetinib和pembrolizumab治疗BRAF V600突变型黑色素瘤成人的初步结果简明摘要。 Dudnichenko, Oleksandr; Penkov, Konstantin; McKean, Meredith; Mandala, Mario; Kukushkina, Mariia; Panella, Timothy; Csoszi, Tibor; Gerletti, Paola; Thakur, Mahgull; Poll, Anna; di Pietro, Alessandra; Schadendorf, Dirk 分享 收藏
分享 收藏
First-line encorafenib plus binimetinib and pembrolizumab for advanced BRAF V600-mutant melanoma: Safety lead-in results from the randomized phase III STARBOARD study 一线encorafenib联合binimetinib和pembrolizumab治疗晚期BRAF V600-mutant黑色素瘤: 随机III期STARBOARD研究的安全导入结果 Dudnichenko, Oleksandr; Penkov, Konstantin; Mckean, Meredith; Mandala, Mario; Kukushkina, Mariia; Panella, Timothy; Csoszi, Tibor; Gerletti, Paola; Thakur, Mahgull; Polli, Anna; di Pietro, Alessandra; Schadendorf, Dirk 分享 收藏
Efficacy and safety of pembrolizumab in patients with advanced urothelial carcinoma deemed potentially ineligible for platinum-containing chemotherapy: Post hoc analysis of KEYNOTE-052 and LEAP-011 O'Donnell, Peter H.; Loriot, Yohann; Csoszi, Tibor; Matsubara, Nobuaki; Shin, Sang Joon; Park, Se Hoon; Atduev, Vagif; Gumus, Mahmut; Karaca, Saziye Burcak; Grivas, Petros; de Wit, Ronald; Castellano, Daniel E.; Powles, Thomas; Vuky, Jacqueline; Zhao, Yujie; O'Hara, Karen; Okpara, Chinyere E.; Franco, Sonia; Moreno, Blanca Homet; Zolnierek, Jakub; Siefker-Radtke, Arlene O. 分享 收藏
Lower pre-treatment B-cell gene expression signatures correspond with improved overall survival with palbociclib plus endocrine therapy in HR+/HER2-metastatic breast cancer: a biomarker analysis from the GEICAM/2013-02 PEARL trial Agrawal, Yash; Fernandez-Martinez, Aranzazu; Gil-Gil, Miguel; Zielinski, Christoph; Ruiz-Borrego, Manuel; Ciruelos, Eva; Munoz, Montserrat; Margeli, Mireia; Bermejo, Begona; Anton, Antonio; Kahan, Zsuzsanna; Csoszi, Tibor; Alonso-Romero, Jose L.; Garcia-Saenz, Jose Angel; Sanchez-Rovira, Pedro; Alvarez, Elena; Chacon, J. Ignacio; Gonzalez-Santiago, Santiago; Rodriguez, Cesar A.; Servitja, Sonia; Pfefferle, Adam D.; Herranz, Jesus; Liu, Yuan; Carey, Lisa A.; Romero-Camarero, Isabel; Caballero, Rosalia; Perou, Charles M.; Martin, Miguel 分享 收藏
Body Mass Index and Treatment Efficacy in advanced Luminal Breast Cancer: Insights from the GEICAM/2013-02 (PEARL) trial Alva, Manuel; Lopez-Tarruella, Sara; Zielinski, Christoph; Ruiz-Borrego, Manuel; Turner, Nicholas; Ciruelos, Eva; Munoz, Montserrat; Bermejo, Begona; Margeli, Mireia; Anton, Antonio; Kahan, Zsuzsanna; Csoszi, Tibor; Casas, Maribel; Murillo, Laura; Murillo, Serafin Morales; Alba, Emilio; Yam, Einav Nili-Gal; Guerrero, Angel; Calvo, Lourdes; de la Haba-Rodriguez, Juan; Ramos, Manuel; Alvarez, Isabel; Garcia-Palomo, Andres; Koehler, Maria; Garcia-Saenz, Jose Angel; Chacon, J. Ignacio; Swift, Claire; Thallinger, Christiane; Gil-Gil, Miguel; Martin, Miguel 分享 收藏
Association of circulating free DNA (cfDNA) maximum variant allele frequency (mVAF) levels with clinical outcomes in patients (pts) with metastatic nonsquamous non-small cell lung cancer (NSCLC) treated with pembrolizumab (pembro) plus chemotherapy (chemo) in the phase 2 KEYNOTE-782 trial Bar, Jair; Esteban, Emilio; Rodriguez-Abreu, Delvys; Ponce-Aix, Santiago; Szalai, Zsuzsanna; Felip, Enriqueta; Gottfried, Maya; Pulla, Mariano Provencio; Robinson, Andrew; Fulop, Andrea; Rao, Suman Bannur; Camidge, D. Ross; Speranza, Giovanna; Hunkapiller, Nathan; McDaniel, Robert; Jung, Byoungsok; Burkhardt, David; Mauntz, Ruth; Chen, Cai; Pena, Carol; Cristescu, Razvan; Dettman, Elisha J.; Townson, Steven M.; Kobie, Julie; Csoszi, Tibor 分享 收藏
Results from KEYNOTE-B99: Phase 2 study of first-line (1L) pembrolizumab (pembro) plus investigational agents and chemotherapy (chemo) for extensive-stage small-cell lung cancer (ES-SCLC) Rodriguez-Abreu, Delvys; Hochmair, Maximillian; Cho, Byoung Chul; Csoszi, Tibor; Kutiel, Talia Shentzer; Mueller, Veronika; Ahn, Myung-Ju; Kowalski, Dariusz; Maio, Michele; Moiseyenko, Vladimir; Navarro, Alejandro; Niu, Jianxin; Fung, Andrea S.; Lips, Carolin; Zhou, Heng; Zhao, Bin; Lara-Guerra, Humberto; Peled, Nir 分享 收藏
Results from KEYMAKER-U01 substudy 3: a phase 2 umbrella study of pembrolizumab plus investigational agents in patients with non-small-cell lung cancer (NSCLC) previously treated with anti-PD-(L)1 therapy Aggarwal, Charu; Stevenson, James; Kowalski, Dariusz M.; Csoszi, Tibor; Peled, Nir; Cho, Byoung Chul; Rubio-Viqueira, Belen; Niu, Jiaxin; Carbone, David P.; Arnold, Susanne M.; Awad, Mark M.; Gainor, Justin F.; Rao, Suman; Tsao, Anne S.; Zhou, Heng; Akala, Omobolaji O.; Chartash, Elliot; Nadal, Ernest 分享 收藏
A phase II study of retifanlimab, a humanized anti-PD-1 monoclonal antibody, in patients with solid tumors (POD1UM-203) Di Giacomo, A. M.; Schenker, M.; Medioni, J.; Mandziuk, S.; Majem, M.; Gravis, G.; Cornfeld, M.; Ranganathan, S.; Lou, S.; Csoszi, T. 分享 收藏
Pembrolizumab with or Without Lenvatinib as First-line Therapy for Patients with Advanced Urothelial Carcinoma (LEAP-011): A Phase 3, Randomized, Double-Blind Trial Matsubara, Nobuaki; de Wit, Ronald; Balar, Arjun Vasant; Siefker-Radtke, Arlene O.; Zolnierek, Jakub; Csoszi, Tibor; Shin, Sang Joon; Park, Se Hoon; Atduev, Vagif; Gumus, Mahmut; Su, Yu -Li; Karaca, Saziye Burcak; Cutuli, Hernan Javier; Sendur, Mehmet A. N.; Shen, Liji; O'Hara, Karen; Okpara, Chinyere E.; Franco, Sonia; Moreno, Blanca Homet; Grivas, Petros; Loriot, Yohann 分享 收藏
Patient-Reported Health-Related Quality of Life in KEYNOTE-604: Pembrolizumab or Placebo Added to Etoposide and Platinum as First-Line Therapy for Extensive SCLC Kim, Hye Ryun; Awad, Mark M.; Navarro, Alejandro; Gottfried, Maya; Peters, Solange; Csoszi, Tibor; Cheema, Parneet K.; Rodriguez-Abreu, Delvys; Wollner, Mirjana; Yang, James Chih-Hsin; Mazieres, Julien; Orlandi, Francisco J.; Luft, Alexander; Gumus, Mahmut; Kato, Terufumi; Kalemkerian, Gregory P.; Luo, Yiwen; Santorelli, Melissa L.; Pietanza, M. Catherine; Rudin, Charles M. 分享 收藏
分享 收藏
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study Fruquintinib与安慰剂在难治性转移性结直肠癌患者中的比较 (FRESCO-2): 一项国际，多中心，随机，双盲，3期研究 Dasari, Arvind; Lonardi, Sara; Garcia-Carbonero, Rocio; Elez, Elena; Yoshino, Takayuki; Sobrero, Alberto; Yao, James; Garcia-Alfonso, Pilar; Kocsis, Judit; Gracian, Antonio Cubillo; Sartore-Bianchi, Andrea; Satoh, Taroh; Randrian, Violaine; Tomasek, Jiri; Chong, Geoff; Paulson, Andrew Scott; Masuishi, Toshiki; Jones, Jeremy; Csoszi, Tibor; Cremolini, Chiara; Ghiringhelli, Francois; Shergill, Ardaman; Hochster, Howard S.; Krauss, John; Bassam, Ali; Ducreux, Michel; Elme, Anneli; Faugeras, Laurence; Kasper, Stefan; Van Cutsem, Eric; Arnold, Dirk; Nanda, Shivani; Yang, Zhao; Schelman, William R.; Kania, Marek; Tabernero, Josep; Eng, Cathy 分享 收藏
Response to firstline (1L) pembrolizumab (pembro) plus chemotherapy (chemo) in nonsmall cell lung cancer (NSCLC) by blood tumor mutational burden (bTMB): the phase 2 KEYNOTE-782 trial Bar, Jair; Esteban, Emilio; Rodriguez-Abreu, Delvys; Aix, Santiago Ponce; Szalai, Zsuzsanna; Felip, Enriqueta; Gottfried, Maya; Pulla, Mariano Provencio; Robinson, Andrew; Fulop, Andrea; Rao, Suman B.; Camidge, D. Ross; Speranza, Giovanna; Townson, Steven M.; Kobie, Julie; Ayers, Mark; Dettman, Elisha J.; McDaniel, Robert; Jung, Byoungsok; Burkhardt, David; Mauntz, Ruth; Csoszi, Tibor 分享 收藏
Trifluridine-tipiracil plus bevacizumab versus capecitabine plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer ineligible for intensive therapy (SOLSTICE): a randomised, open-label phase 3 study 氟尿嘧啶-替比拉西联合贝伐单抗与卡培他滨联合贝伐单抗一线治疗不适合强化治疗的转移性结直肠癌患者 (SOLSTICE): 一项随机、开放标签的3期研究 Andre, Thierry; Falcone, Alfredo; Shparyk, Yaroslav; Moiseenko, Fedor; Polo-Marques, Eduardo; Csoszi, Tibor; Campos-Bragagnoli, Arinilda; Liposits, Gabor; Chmielowska, Ewa; Aubel, Paul; Martin, Lourdes; Fougeray, Ronan; Amellal, Nadia; Saunders, Mark P. 分享 收藏
Overall survival with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer in the PEARL study PEARL研究中激素受体阳性、HER2-negative转移性乳腺癌绝经后患者接受palbociclib联合内分泌治疗与卡培他滨治疗的总生存率比较 Martin, Miguel; Zielinski, Christoph; Ruiz-Borrego, Manuel; Carrasco, Eva; Ciruelos, Eva M.; Munoz, Montserrat; Bermejo, Begona; Margeli, Mireia; Csoszi, Tibor; Anton, Antonio; Turner, Nicholas; Casas, Maria, I; Morales, Serafin; Alba, Emilio; Calvo, Lourdes; De La Haba-Rodriguez, Juan; Ramos, Manuel; Murillo, Laura; Santaballa, Ana; Alonso-Romero, Jose L.; Sanchez-Rovira, Pedro; Corsaro, Massimo; Huang, Xin; Thallinger, Christiane; Kahan, Zsuzsanna; Gil-Gil, Miguel 分享 收藏
.png){kind=icon}
.png){kind=icon}
.png)
OAAI
.png){kind=icon}
分享.png){kind=icon}
收藏
.png)
CANCER RESEARCH